|
Volumn 23, Issue 3 SUPPL. 7, 1996, Pages 8-11
|
Ifosfamide in the treatment of pediatric malignancies
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
IPROPLATIN;
VINCRISTINE;
BONE MARROW TOXICITY;
BRAIN TUMOR;
CANCER COMBINATION CHEMOTHERAPY;
CHILD;
CHILDHOOD CANCER;
CLINICAL TRIAL;
EWING SARCOMA;
FANCONI RENOTUBULAR SYNDROME;
FEMALE;
HEMORRHAGIC CYSTITIS;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MALE STERILITY;
MEDULLOBLASTOMA;
MENOPAUSE;
MULTICENTER STUDY;
NEPHROBLASTOMA;
NEPHROTOXICITY;
NEUROBLASTOMA;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
RHABDOMYOSARCOMA;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRAIN NEOPLASMS;
CHILD;
HUMANS;
IFOSFAMIDE;
LYMPHOMA, NON-HODGKIN;
NEUROBLASTOMA;
OSTEOSARCOMA;
RHABDOMYOSARCOMA;
SARCOMA, EWING'S;
WILMS TUMOR;
|
EID: 0029739682
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (18)
|
References (0)
|